Literature DB >> 28991564

Imaging and Screening of Ovarian Cancer.

Kathryn P Lowry1, Susanna I Lee2.   

Abstract

Ovarian cancer has a high mortality, attributed to its typically advanced stage at detection. Despite much effort to identify an effective approach for ovarian cancer screening, to date no screening test has proven to reduce ovarian cancer mortality. The natural history of ovarian cancer is reviewed as well as data from the largest trials of ovarian cancer screening. Currently, no North American society recommends routine ovarian cancer screening; some societies recommend consideration of screening with pelvic ultrasound and CA-125 in women at high risk, although its use in this setting is not supported by data demonstrating a mortality benefit.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer screening; Ovarian cancer; Randomized trials; Transvaginal ultrasound

Mesh:

Substances:

Year:  2017        PMID: 28991564     DOI: 10.1016/j.rcl.2017.06.010

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  8 in total

1.  Radiologic-Histopathologic Correlation of Transvaginal US and Risk-reducing Salpingo-oophorectomy for Women at High Risk for Tubo-ovarian Carcinoma.

Authors:  Michelle D Sakala; Nicole E Curci; William R Masch; Mishal Mendiratta-Lala; Erica B Stein; Ashish P Wasnik; Andrew P Sciallis; Shitanshu Uppal; Mark D Pearlman; Katherine E Maturen
Journal:  Radiol Imaging Cancer       Date:  2020-11-13

Review 2.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

3.  Clinicopathological features and maternal and foetal management of pregnancy-complicating Krukenberg tumours.

Authors:  Jingjing Zhang; Peng Peng; Dongyan Cao; Jiaxin Yang; Keng Shen
Journal:  Mol Clin Oncol       Date:  2020-03-30

4.  MicroRNA-126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial-to-mesenchymal transition and ERK/MAPK signaling pathway.

Authors:  Yuhua Zhang; Xiaobo Qin; Juan Jiang; Wenjie Zhao
Journal:  Oncol Lett       Date:  2020-05-29       Impact factor: 2.967

5.  Diagnostic Value of Two-Dimensional Transvaginal Ultrasound Combined with Contrast-Enhanced Ultrasound in Ovarian Cancer.

Authors:  Rong Hu; Gulina Shahai; Hui Liu; Yuling Feng; Hong Xiang
Journal:  Front Surg       Date:  2022-05-27

6.  Ovarian cancer circulating extracelluar vesicles promote coagulation and have a potential in diagnosis: an iTRAQ based proteomic analysis.

Authors:  Wei Zhang; Peng Peng; Xiaoxuan Ou; Keng Shen; Xiaohua Wu
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430

7.  Ovarian metastasis from nongynecologic primary sites: a retrospective analysis of 177 cases and 13-year experience.

Authors:  Jing-Jing Zhang; Dong-Yan Cao; Jia-Xin Yang; Keng Shen
Journal:  J Ovarian Res       Date:  2020-10-27       Impact factor: 4.234

8.  A decision support system based on radiomics and machine learning to predict the risk of malignancy of ovarian masses from transvaginal ultrasonography and serum CA-125.

Authors:  Valentina Chiappa; Matteo Interlenghi; Giorgio Bogani; Christian Salvatore; Francesca Bertolina; Giuseppe Sarpietro; Mauro Signorelli; Dominique Ronzulli; Isabella Castiglioni; Francesco Raspagliesi
Journal:  Eur Radiol Exp       Date:  2021-07-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.